Brind.
  1. WuXi Biologics maintains operational bases in China and leverages a global CRDMO network for client support.

DP15 achieved GMP release in April by leveraging the global CRDMO network capabilities.

1 report, 1 independent Updated May 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

DP15 achieved GMP release in April by leveraging the global CRDMO network capabilities.

Who's involved

What this event is mainly about
WuXi Biologics

Keep exploring

Part of

WuXi Biologics maintains operational bases in China and leverages a global CRDMO network for client support. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped